NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Picard Medical, Inc. ("Picard Medical, Inc." or the "Company") (NYSE: PMI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Picard Medical, Inc. investors who were adversely affected by alleged securities fraud between September 2, 2025 and October 31, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 17, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Charming Medical Limited ("Charming†or the "Company†) (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CHARMING MEDICAL LIMITED (MCTA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PA. ...

Deadline Alert: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitFeb 12, 2026 2:35 PM Eastern Standard Time# Deadline Alert: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitShare---LOS ANGELES--([BUSINESS WIRE])- - [Glancy Prongay Wolke & Rotter LLP] reminds investors of the upcoming February 17, 2026 deadline to file a lead ...

Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. for allegedly issuing false and misleading statements during a specific class period from September 2, 2025, to October 31, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities that purchased or acquired Picard shares during the class period [1] - Investors have until April 3, 2026, to seek appointments as lead plaintiff [1][2] Group 2: Allegations Against Picard Medical - The complaint alleges that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [6] - Insiders and/or affiliates reportedly used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [6] - Picard's public statements and risk disclosures allegedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [6]

Washington, the District Of Columbia-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services. The company is valued at $153 billion by market cap. Shares of global science and technology conglomerate have underperformed the broader market over the past year. DHR has gained 8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 14.4%. In 2026, DHR stock is down 4%, compared to the SPX’s 1.4% rise on ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against Picard Medical, Inc. on behalf of investors who acquired its securities during the specified class period from September 2, 2025, to October 31, 2025 [1] Group 1 - The lawsuit is initiated by Glancy Prongay Wolke & Rotter LLP, a prominent national shareholder rights law firm [1] - Investors have until April 3, 2026, to file a lead plaintiff motion [1]

Core Viewpoint - A securities fraud class action lawsuit has been filed against Richtech Robotics Inc. (RR) on behalf of investors who acquired its securities between January 27, 2026, and January 29, 2026, following misleading statements regarding a collaboration with Microsoft [1] Group 1: Company Overview - Richtech Robotics Inc. announced a collaboration with Microsoft's AI Co-Innovation Labs on January 27, 2026, which led to a 44.6% increase in its stock price [1] - On January 29, 2026, Hunterbrook Media reported that the collaboration was merely a "standard" customer program with "no commercial element," resulting in a stock price drop of $1.06, or 20.9%, closing at $4.02 per share [1] Group 2: Lawsuit Details - The lawsuit alleges that Richtech made materially false and misleading statements and failed to disclose adverse facts about its business and prospects [1] - Specifically, it is claimed that Richtech misrepresented its relationship with Microsoft, leading to misleading positive statements about the company's operations [1]

Core Viewpoint - A class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) for alleged fraudulent activities related to stock promotion schemes that misled investors during the period from October 10, 2025, to November 12, 2025 [7]. Allegation Details - The lawsuit claims that Charming failed to disclose involvement in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [7]. - Insiders allegedly used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [7]. - The company's public statements and risk disclosures did not mention the false rumors and artificial trading activity that inflated the stock price [7]. Stock Performance - Charming's share price increased from an initial public offering price of $4.00 to a peak of $29.36 per share, despite no fundamental news justifying such a rise [7]. - Investigations revealed that the stock was subject to an illicit promotion scheme that artificially inflated its price through sensational claims made by impersonators in online forums and social media [7]. Regulatory Actions - On November 12, 2025, the SEC halted trading of Charming's stock, which remains suspended as the company has not provided the necessary information to lift the suspension [7].

Core Viewpoint - Picard Medical, Inc. is facing a class action lawsuit due to allegations of fraudulent activities that misled investors during a specific period, leading to significant stock price declines [1][3]. Group 1: Class Action Details - The class action is on behalf of investors who purchased securities between September 5, 2025, and October 31, 2025, with a deadline for filing a lead plaintiff motion set for April 3, 2026 [1]. - Investors are encouraged to contact the Portnoy Law Firm for legal rights discussions and case evaluations [2]. Group 2: Allegations Against Picard Medical - The complaint alleges that Picard failed to disclose involvement in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [3]. - It is claimed that insiders and affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [3]. - The company's public statements and risk disclosures reportedly omitted critical information regarding false rumors and artificial trading activity that influenced the stock price [3]. Group 3: Stock Price Impact - On October 24, 2025, Picard's stock price experienced a drastic decline of 70%, dropping to $3.99 per share, and has since further decreased to approximately $2.00 per share [3].

Group 1 - The DJS Law Group has announced a class action lawsuit against Picard Medical, Inc. for violations of the Securities Exchange Act of 1934 and related SEC rules [1] - The class period for the lawsuit is from September 2, 2025, to October 31, 2025, with a deadline for lead plaintiff appointments set for April 3, 2026 [2] - The complaint alleges that Picard Medical made false and misleading statements to the market, benefiting from a stock manipulation scheme that inflated its share price [2] Group 2 - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential participation in the lawsuit [2][3] - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4]